RVS Consensus+ is a leading independent provider of derivative pricing services for the OTC Global Derivative Markets. The company has pioneered the use of Transaction Evidence to Back Test Consensus+ information in the creation and calculation of financial rate sets and surfaces, ensuring accuracy and transparency. RVS Consensus+ Services cover all OTC products, contributing to increased capital efficiency, improved risk and valuation management processes, and reduced risk of manipulation and malpractice.
Founded in 2009, RVS operates in Asia, Europe, and Australia, offering accuracy, transparency, and efficiency in the valuation and validation process of complex financial products. The company's key philosophy revolves around putting customers' needs first to make their lives easier, ensuring quality as part of their customers' business as usual, and continually improving and enhancing their service offerings, both large and small.
RVS's focus on utilizing transaction evidence in accordance with industry recommendations and legislation, such as IOSCO Principles for Financial Benchmarks, PruVal, FRTB, and MiFIDII, underpins its commitment to integrity in calculations and compliance with regulations.
Being in the Financial Services industry, RVS Consensus+ is positioned as a significant player in providing essential derivative pricing services, offering a transparent and trustworthy solution to the industry’s increasing complexity and opacity, benefiting banks and market participants alike.
